July 10 (Reuters) - Compumedics Ltd CMP.AX :
* PRELIM H2 REVENUES AT ABOUT $17M
* PRELIMINARY PRELIM FY20 REVENUES $35.3M (NYSE:MMM), DOWN 15%
* INITIAL SALES PIPELINES FOR FY21 CONSISTENT WITH SAME TIME LAST YEAR
* POSITIVE EBITDA FOR FY20 SHOULD RESULT FROM IMMEDIATE EXPENSE MITIGATION MEASURES TAKEN AND VARIOUS GOVERNMENT ASSISTANCE OBTAINED